May 13, 2020
Securities and Exchange Commission
Division of Corporation Finance
100 F Street N.E.
Washington, D.C. 20549
| Attention: | Division of Corporation Finance, |
| Office of Life Sciences |
VIA EDGAR
| Re: | Medigus Ltd. (the “Company”) |
Registration Statement on Form F-3 (the “Registration Statement”)
Filed on May 11, 2020
File No. 333-238162
Dear Madam or Sir:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, the Company respectfully requests that the effectiveness of the registration statement on Form F-3 (File No. 333-238162) of the Company (the “Registration Statement”) be accelerated so that the Company’s Registration Statement will become effective at 08:30 a.m., Eastern Time, on May 15, 2020 or as soon thereafter as may be practicable.
The undersigned respectfully requests that it be notified of the effectiveness of the Registration Statement by email to our counsel, Meitar Law Offices, by emailing Dr. Shachar Hadar, Esq. at shacharh@meitar.com.
| Sincerely, | |
| /s/ Liron Carmel | |
| Liron Carmel | |
| Chief Executive Officer | |
| Medigus Ltd. |